Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers

Alzheimer's and Dementia

Volumn 10, Issue 2, 2014, Pages 251-261

  Chang, Lily Y L ^a   Lowe, Jennifer ^a   Ardiles, Alvaro ^b   Lim, Julie ^a   Grey, Angus C ^a   Robertson, Ken ^a   Danesh Meyer, Helen ^a   Palacios, Adrian G ^b   Acosta, Monica L ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

Amyloid; Ganglion cells; Glaucoma; Retina; Retinal degeneration

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; BLOOD VESSEL; BRAIN MICROCIRCULATION; COLOR VISION; CONTRAST SENSITIVITY; HUMAN; LENS; MOTOR PERFORMANCE; MOVEMENT PERCEPTION; NERVE DEGENERATION; NEUROCHEMISTRY; OPTIC NERVE; PRIORITY JOURNAL; PUPIL REFLEX; RETINA; STEREOSCOPIC VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL INFORMATION;

AMYLOID; GANGLION CELLS; GLAUCOMA; RETINA; RETINAL DEGENERATION;

ALZHEIMER DISEASE; EYE DISEASES; HUMANS; VISUAL PATHWAYS;

EID: 84897489303     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.06.004     Document Type: Review

References (67)

1. Alzheimer's Association 2012 Alzheimer's disease facts and figures Alzheimers Dement 8 2012 131 168
2. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
3. F. Berisha, G.T. Feke, C.L. Trempe, J.W. McMeel, and C.L. Schepens Retinal abnormalities in early Alzheimer's disease Invest Ophthalmol Vis Sci 48 2007 2285 2289
4. H.V. Danesh-Meyer, H. Birch, J.Y. Ku, S. Carroll, and G. Gamble Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging Neurology 67 2006 1852 1854
5. L.E. Goldstein, J.A. Muffat, R.A. Cherny, R.D. Moir, M.H. Ericsson, and X. Huang et al. Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease Lancet 361 2003 1258 1265
6. M.K. Ikram, C.Y. Cheung, M. Lorenzi, R. Klein, T.L. Jones, and T.Y. Wong Retinal vascular caliber as a biomarker for diabetes microvascular complications Diabetes Care 36 2013 750 759
7. L. Gasparini, R.A. Crowther, K.R. Martin, N. Berg, M. Coleman, and M. Goedert et al. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability Neurobiol Aging 32 2011 419 433
8. M. Koronyo-Hamaoui, Y. Koronyo, A.V. Ljubimov, C.A. Miller, M.K. Ko, and K.L. Black et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model Neuroimage 54 suppl 1) 2011 S204 S217
9. D.A. Lewis, M.J. Campbell, R.D. Terry, and J.H. Morrison Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices J Neurosci 7 1987 1799 1808
10. D.R. Hinton, A.A. Sadun, J.C. Blanks, and C.A. Miller Optic-nerve degeneration in Alzheimer's disease N Engl J Med 315 1986 485 487
11. C. Paquet, M. Boissonnot, F. Roger, P. Dighiero, R. Gil, and J. Hugon Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease Neurosci Lett 420 2007 97 99
12. B. Liu, S. Rasool, Z. Yang, C.G. Glabe, S.S. Schreiber, and J. Ge et al. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice Am J Pathol 175 2009 2099 2110
13. S.X. Zhang-Nunes, M.L. Maat-Schieman, S.G. van Duinen, R.A. Roos, M.P. Frosch, and S.M. Greenberg The cerebral beta-amyloid angiopathies: hereditary and sporadic Brain Pathol 16 2006 30 39
14. A.O. Ardiles, C.C. Tapia-Rojas, M. Mandal, F. Alexandre, A. Kirkwood, and N.C. Inestrosa et al. Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease Proc Natl Acad Sci U S A 109 2012 13835 13840
15. A.O. Ardiles, J. Ewer, M.L. Acosta, A. Kirkwood, A. Martinez, and L. Ebensperger et al. Octodon degus (Molina 1782): a model in comparative biology and biomedicine Cold Spring Harb Protoc 2013 2013 312 318
16. J. Bruban, V. Dinet, and F. Mascarelli The role of amyloid-β in retinal degeneration Adv Exp Med Biol 723 2012 67 74
17. J.M. Isas, V. Luibl, L.V. Johnson, R. Kayed, R. Wetzel, and C.G. Glabe et al. Soluble and mature amyloid fibrils in drusen deposits Invest Ophthalmol Vis Sci 51 2010 1304 1310
18. N.D. Bull, A. Guidi, M. Goedert, K.R. Martin, and M.G. Spillantini Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau PLoS One 7 2012 e34724
19. P.T. Francis, A.M. Palmer, M. Snape, and G.K. Wilcock The cholinergic hypothesis of Alzheimer's disease: a review of progress J Neurol Neurosurg Psychiatry 66 1999 137 147
20. R.H. Masland, and M. Tauchi The cholinergic amacrine cell Trends Neurosci 9 1986 218 223
21. M. Schmidt, M. Humphrey, and H. Wassle Action and localization of acetylcholine in the cat retina J Neurophysiol 58 1987 997 1015
22. J. Cunningham, C. Dawson, and M. Neal Evidence for a cholinergic inhibitory feed-back mechanism in the rabbit retina J Physiol 340 1983 455 468
23. L. Nobili, and W.G. Sannita Cholinergic modulation, visual function and Alzheimer's dementia Vision Res 37 1997 3559 3571
24. K. Strenn, P. Dal-Bianco, H. Weghaupt, G. Koch, C. Vass, and I. Gottlob Pattern electroretinogram and luminance electroretinogram in Alzheimer's disease J Neural Transm Suppl 33 1991 73 80
25. P.K. Iseri, O. Altinas, T. Tokay, and N. Yuksel Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease J Neuroophthalmol 26 2006 18 24
26. H. Kergoat, M.J. Kergoat, L. Justino, H. Chertkow, A. Robillard, and H. Bergman An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type Acta Ophthalmol Scand 79 2001 187 191
27. J.C. de la Torre Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol 57 2005 783 784
28. C.Y. Cheung, W.T. Tay, P. Mitchell, J.J. Wang, W. Hsu, and M.L. Lee et al. Quantitative and qualitative retinal microvascular characteristics and blood pressure J Hypertens 29 2011 1380 1391
29. T.T. Nguyen, R. Kawasaki, J.J. Wang, A.J. Kreis, J. Shaw, and W. Vilser et al. Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy Diabetes Care 32 2009 2075 2080
30. P.H. Frederikse, D. Garland, J.S. Zigler Jr., and J. Piatigorsky Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells J Biol Chem 271 1996 10169 10174
31. M.F. Simpanya, R. Ansari, K.I. Suh, V.R. Leverenz, and F.J. Giblin Aggregation of lens crystallins in an in vivo hyperbaric oxygen guinea pig model of nuclear cataract: dynamic light-scattering and HPLC analysis Invest Ophthalmol Vis Sci 46 2005 4641 4651
32. G.F. Vrensen, J. Sanderson, B. Willekens, and G. Duncan Calcium localization and ultrastructure of clear and pCMPS-treated rat lenses Invest Ophthalmol Vis Sci 36 1995 2287 2295
33. J.A. Moncaster, R. Pineda, R.D. Moir, S. Lu, M.A. Burton, and J.G. Ghosh et al. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome PLoS One 5 2010 e10659
34. R. Michael, J. Rosandic, G.A. Montenegro, E. Lobato, F. Tresserra, and R.I. Barraquer et al. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease Exp Eye Res 106 2013 5 13
35. I.D. Nicholl, and R. Quinlan Chaperone activity of alpha-crystallins modulates intermediate filament assembly EMBO J 13 1994 945 953
36. J. Liang Interaction between beta-amyloid and lens alphaB-crystallin FEBS Lett 484 2000 98 101
37. A.A. Sadun, M. Borchert, E. DeVita, D.R. Hinton, and C.J. Bassi Assessment of visual impairment in patients with Alzheimer's disease Am J Ophthalmol 104 1987 113 120
38. A. Cronin-Golomb, S. Corkin, J.F. Rizzo, J. Cohen, J.H. Growdon, and K.S. Banks Visual dysfunction in Alzheimer's disease: relation to normal aging Ann Neurol 29 1991 41 52
39. G.C. Gilmore, H.E. Wenk, L.A. Naylor, and E. Koss Motion perception and Alzheimer's disease J Gerontol 49 1994 P52 P57
40. G.C. Gilmore, S. Morrison, and K.E. Groth Magnocellular deficit hypothesis in Alzheimer's disease Interdisciplinary topics in gerontology: Vision in Alzheimer's disease and related disorders 2004 173 198
41. R.F. Uhlmann, E.B. Larson, T.D. Koepsell, T.S. Rees, and L.G. Duckert Visual impairment and cognitive dysfunction in Alzheimer's disease J Gen Intern Med 6 1991 126 132
42. M. Rizzo, S.W. Anderson, J. Dawson, and M. Nawrot Vision and cognition in Alzheimer's disease Neuropsychologia 38 2000 1157 1169
43. F.K. Cormack, M. Tovee, and C. Ballard Contrast sensitivity and visual acuity in patients with Alzheimer's disease Int J Geriatr Psychiatry 15 2000 614 620
44. A.V. Lakshiminarayanan, and V. Sasisekharan Stereochemistry of nucleic acids and polynucleotides. II. Allowed conformations of the monomer unit for different ribose puckerings Biochim Biophys Acta 204 1970 49 59
45. S.A. Neargarder, E.R. Stone, A. Cronin-Golomb, and S. Oross The impact of acuity on performance of four clinical measures of contrast sensitivity in Alzheimer's disease J Gerontol B Psychol Sci Soc Sci 58 2003 P54 P62
46. C.T. Scialfa, D.W. Kline, and P.K. Wood Structural modeling of contrast sensitivity in adulthood J Opt Soc Am A Opt Image Sci Vis 19 2002 158 165
47. G.C. Gilmore, K.E. Groth, and C.W. Thomas Stimulus contrast and word reading speed in Alzheimer's disease Exp Aging Res 31 2005 15 33
48. J.B. Kerrison, K. Buchanan, M.L. Rosenberg, R. Clark, K. Andreason, and D.V. Alfaro et al. Quantification of optic nerve axon loss associated with a relative afferent pupillary defect in the monkey Arch Ophthalmol 119 2001 1333 1341
49. E. Granholm, S. Morris, D. Galasko, C. Shults, E. Rogers, and B. Vukov Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease Int J Psychophysiol 47 2003 95 115
50. R. Prettyman, P. Bitsios, and E. Szabadi Altered pupillary size and darkness and light reflexes in Alzheimer's disease J Neurol Neurosurg Psychiatry 62 1997 665 668
51. A. Takagi, M. Miyao, S. Ishihara, H. Sakakibara, T. Kondo, and H. Toyoshima et al. Sensitive pupil response of early-onset Alzheimer's patients to a dilute mixture of cholinergic antagonist and alpha-Adrenergic stimulant Environ Health Prev Med 4 1999 49 53
52. J. Idiaquez, G. Alvarez, R. Villagra, and R. San Martin Cholinergic supersensitivity of the iris in Alzheimer's disease J Neurol Neurosurg Psychiatry 57 1994 1544 1545
53. S. Borson, R.F. Barnes, R.C. Veith, J.B. Halter, and M.A. Raskind Impaired sympathetic nervous system response to cognitive effort in early Alzheimer's disease J Gerontol 44 1989 M8 M12
54. H. Wijk, S. Berg, L. Sivik, and B. Steen Colour discrimination, colour naming and colour preferences among individuals with Alzheimer's disease Int J Geriatr Psychiatry 14 1999 1000 1005
55. D.D. Kurylo, S. Corkin, R.P. Dolan, J.F. Rizzo, S.W. Parker, and J.H. Growdon Broad-band visual capacities are not selectively impaired in Alzheimers disease Neurobiol Aging 15 1994 305 311
56. M. Pache, C.H.W. Smeets, P. Gasio, E. Savaskan, J. Flammer, and A. Wirz-Justice et al. Colour vision deficiencies in Alzheimer's disease Age Ageing 32 2003 422 426
57. Köllner H. Die Störungen des Farbensinnes ihre klinische Bedeutung und ihre Diagnose. In. Berlin; 1912.
58. R.L. Radius, and D.R. Anderson The course of axons through the retina and optic nerve head Arch Ophthalmol 97 1979 1154 1158
59. G.L. Trick, L.R. Trick, P. Morris, and M. Wolf Visual field loss in senile dementia of the Alzheimer's type Neurology 45 1995 68 74
60. D.A. Valenti, T. Laudate, and A. Cronin-Golomb Vision screening of Alzheimer's disease with frequency doubling technology (FDT) Invest Ophth Vis Sci 45 2004 U148
61. P.R. Hof, and J.H. Morrison Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex J Comp Neurol 301 1990 55 64
62. V.S. Pelak Ocular motility of aging and dementia Curr Neurol Neurosci Rep 10 2010 440 447
63. W.A. Fletcher, and J.A. Sharpe Saccadic eye movement dysfunction in Alzheimer's disease Ann Neurol 20 1986 464 471
64. L.F. Scinto, K.R. Daffner, L. Castro, S. Weintraub, M. Vavrik, and M.M. Mesulam Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movements Arch Neurol 51 1994 682 688
65. K. Uomori, S. Murakami, M. Yamada, M. Fujii, H. Yoshimatsu, and N. Nakano et al. Analysis of gaze shift in depth in Alzheimer's disease patients IEICE Trans Info Syst 76 1993 963 973
66. S.N. Thiyagesh, T.F. Farrow, R.W. Parks, H. Accosta-Mesa, C. Young, and I.D. Wilkinson et al. The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study Psychiatry Res 172 2009 109 116
67. A.J. Anderson, and C.A. Johnson Frequency-doubling technology perimetry Ophthalmol Clin North Am 16 2003 213 225